Meropenem Use Pattern at Srinagarind Hospital

Main Article Content

Ratchadaporn Soontornpas
Thanida Nuntasaen
Piroon Mootsikapun
Siriluk Jaisue
Cheardchai Soontornpas

Abstract

Introduction: Meropenem is an antimicrobial in the National List of Essential Medicines of Thailand which has been substantially used and needs drug use evaluation program to optimize rational drug utilization in Srinagarind Hospital. Objectives: To study meropenem use pattern in fields of indication and dosage regimen. Methods: The medical records of hospitalized patients who received meropenem during July 2014 to September 2014 were reviewed retrospectively. The relevant data including patient demographic background, type of infection, type of therapy, dosage regimen and duration of therapy, was collected. Results: A total of 106 patients met the inclusion criteria and were recruited to the study. Meropenem was used as empiric therapy (65.1%) and documented therapy (34.9%). Respiratory tract infection was the major organ of infection (38.7%) followed by sepsis (36.8%).The usual dosage regimenwas 1 g every 8 h (58.5%) and the dosage regimen were adjusted according to renal function. Duration of therapy was usually up to 14 d (85.9%) Conclusion: The use of meropenem at Srinagarind Hospital was considerable rationale in either indication or dosage regimen which compliedwith the hospital guideline for antimicrobials use.

Article Details

Section
Pharmaceutical Practice

References

Ayuthya SK, Matangkasombut OP, Sirinavin S, Malathum K, Sathapatayavongs B. Utilization of restricted antibiotics in a university hospital in Thailand. Southeast Asian J Trop Med Public Health. 2003 Mar; 34(1): 179-186.

Chelkeba L. Antimicrobials use evaluation in Arba Minch Hospital, GamoGofa zone, South Ethiopia, Ethiopia. African Journal of Pharmacy. 2013 Oct; 1(1): 001-008.

Food and Drug Administration (FDA). National List of Essential Medicines 2004. Bangkok: National Drug System Development Committee; 2004.

MohrJF3rd. Update on the Efficacy and Tolerability of Meropenem in theTreatment of Serious Bacterial Infections. Clin Infect Dis.2008 Sep; 47(1): S41-51.

Ouwuttipong T. Utilization Evaluation of Meropenem at Sukhothai Hospital. Buddhachinaraj Med J. 2008 Jan-Apr;25 (1): 177-184.

Raveh D, Muallem-zilcha E, Greenberg A, Wiener-well Y, Schlesinger Y, Yinnon AM. Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem. QJM. 2006 Jun; 99(6): 397-406.